HIV/Drug Abuse Prevention Research Ethics Training Institute

 描述（由申请人提供）：艾滋病毒/艾滋病大流行的不断演变的性质，药物使用模式的动态变化，药物使用和其他艾滋病毒风险行为的刑事化，沿着新技术的使用和其他治疗和预防方面的快速进步，为涉及药物滥用者的艾滋病毒研究带来了不断变化的伦理挑战。NIH最近呼吁各级研究项目在RCR中包括面对面的指导。然而，很少有项目提供这样的培训，迄今为止，NIDA资助的（DA 031608）福德姆大学艾滋病毒和药物滥用预防研究培训研究所（RETI）是唯一一个为早期职业临床科学家提供知识和能力的项目，以产生经验数据，可以提高艾滋病毒/药物滥用研究伦理实践和政策。这5年的更新将维持和扩大RETI的成功。该研究所的长期目标是培养新一代临床科学家，他们具备解决吸毒人群的健康和人权需要的技能，并满足全球对经验和教育资源的需求，以告知艾滋病毒/药物滥用研究的道德做法和政策。将通过以下具体目标实现这些目标：1.提高早期职业临床科学家对艾滋病毒/药物滥用预防研究中关键伦理问题的认识和解决这些问题的能力; 2.提高早期职业临床科学家让社区参与制定艾滋病毒/药物滥用参与者保护措施的能力; 3.提高早期职业临床科学家对艾滋病毒/药物滥用预防研究伦理做法/政策进行经验性研究的能力; 4：建立并维持全球信息网络，以加强艾滋病毒/药物滥用预防研究伦理方面的伦理知识和循证伦理做法/政策;以及5：提供在线全球资源，以提高其他研究生和研究生培训单位教员辅导和教授艾滋病毒/药物滥用预防研究伦理的能力。 为了实现这些目标，该计划将：（1）从多个学科和国家和国际环境中招募高素质的种族多样性临床科学家;（2）更新为期2年的现场强化课程，以包括对艾滋病毒预防研究设计中新兴伦理问题的新创新重点，其中包括成瘾治疗和减少伤害策略;（3）提供社区参与艾滋病毒/药物滥用研究的设计和传播的经验培训;（4）为学员提供全年的指导和财政支持，开展和传播对人口敏感的实证研究，以便为艾滋病毒/药物滥用预防研究道德政策和做法提供信息;（5）扩大RETI在线公共资源，包括广泛的艾滋病毒/药物滥用研究伦理书目，伦理尺度和措施资源页面，以及伦理与社会博客;（6）创建可下载的网络研讨会，播客，视频讲座和教育模块，供其他研究单位的教师和主管使用。

 DESCRIPTION (provided by applicant): The evolving nature of the HIV/AIDS pandemic, dynamic shifts in drug use patterns, criminalization of drug use and other HIV risk behaviors, along with the use of new technologies and other rapid advances in treatment and prevention create continuously changing ethical challenges for HIV research involving people who abuse drugs. NIH has recently called for research programs at all levels to include face-to-face instruction in RCR. However, few programs provide such training and to date the NIDA funded (DA031608) Fordham University HIV and Drug Abuse Prevention Research Training Institute (RETI) is the only program to provide early career clinical scientists with knowledge of and ability to generate empirical data that can enhance HIV/drug abuse research ethics practices and policies. This 5-year renewal will sustain and expand upon RETI's success. The long-term objectives of the RETI are to produce a new generation of clinical scientists with the skills to address the health and human rights needs of drug using populations and to meet the global need for empirical and educational resources to inform HIV/drug abuse research ethics practices and policies. These objectives will be met through the following specific aims: To 1: increase early career clinical scientists' knowledge of and capacity to address key ethical issues in HIV/drug abuse prevention research; 2: increase early career clinical scientists' capacity to engage communities in the construction of HIV/drug abuse participant protections; 3: increase early career clinical scientists' capacity to conduct empirical research on HIV/drug abuse prevention research ethics practices/policies; 4: create and sustain a global information network for enhancing ethical knowledge and evidence-based ethics practices/policies for HIV/drug abuse prevention research ethics; and 5: provide online global resources to facilitate the ability of faculty in other graduate and post-graduate training units to mentor and teach HIV/drug abuse prevention research ethics. To achieve these aims the program will: (1) recruit highly qualified ethnically diverse clinical scientists from multiple disciplines and national and international settings; (2) update the 2-year intensive on-site curriculum to include a new innovative focus on emerging ethical issues in HIV prevention research designs that incorporate addiction treatment and harm reduction strategies; (3) provide experiential training in community engagement in the design and dissemination of HIV/drug abuse research; (4) provide year-round mentoring and financial support for trainees to design, conduct and disseminate population-sensitive empirical studies to inform HIV/drug abuse prevention research ethics policies and practices; (5) expand RETI on-line public resources including an extensive HIV/drug abuse research ethics bibliography, Ethics Scales and Measures Resources page, and Ethics & Society blog; and (6) create downloadable webinars, podcasts, video lectures, and educational modules for use by faculty and supervisors in other research units.